NCT05118542View on ClinicalTrials.gov

Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 1, 2020

Study Completion Date

August 1, 2020

Conditions
HyperthyroidismGraves DiseaseAtherosclerosis of ArteryPathophysiology
Interventions
DRUG

Propylthiouracil

PTU were given to participants with adjusted dosage according to patient clinical assessment at every visit by their own endocrinologist.

DRUG

Methimazole

methimazole were given to participants with adjusted dosage according to patient clinical assessment at every visit by their own endocrinologist.

Trial Locations (1)

10430

University of Indonesia, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05118542 - Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis | Biotech Hunter | Biotech Hunter